LIke ThisLIke ThisLIke This

George Russell, MD

George Russell, MD
Medicine Research
Gastroenterology, Hepatology and Nutrition Research
Hospital Title:
Director of Fecal Microbe Transplant Program
Academic Title:
Assistant Professor of Pediatrics, Harvard Medical School
Contact Via Email
Send an email to SendYour Name*Your Email Address*Subject*Comments*


Publications powered by Harvard Catalyst Profiles
  1. Russell GH. Too early to determine whether fecal microbiota transplant has therapeutic promise for Ulcerative Colitis? J Pediatr Gastroenterol Nutr. 2015 Jan; 60(1):3.
  2. Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA. 2014 Nov 05; 312(17):1772-8.
  3. Russell GH, Kaplan JL, Youngster I, Baril-Dore M, Schindelar L, Hohmann E, Winter HS. Fecal transplant for recurrent Clostridium difficile infection in children with and without inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014 May; 58(5):588-92.
  4. Youngster I, Sauk J, Pindar C, Wilson RG, Kaplan JL, Smith MB, Alm EJ, Gevers D, Russell GH, Hohmann EL. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis. 2014 Jun; 58(11):1515-22.
  5. Benor S, Russell GH, Silver M, Israel EJ, Yuan Q, Winter HS. Shortcomings of the inflammatory bowel disease Serology 7 panel. Pediatrics. 2010 Jun; 125(6):1230-6.
  6. Fanjiang G, Russell GH, Katz AJ. Short- and long-term response to and weaning from infliximab therapy in pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr. 2007 Mar; 44(3):312-7.
  7. Russell GH, Katz AJ. Infliximab is effective in acute but not chronic childhood ulcerative colitis. J Pediatr Gastroenterol Nutr. 2004 Aug; 39(2):166-70.
LIke ThisLIke ThisLIke This